European Companies Search Engine
EU funding (€159,461): Development of a new immunoassay platform based on porous antibody microparticles Hor26 Jun 2015 EU Research and Innovation programme "Horizon"
Overview
Text
Development of a new immunoassay platform based on porous antibody microparticles
Rapid and sensitive analyte determination in small volumes is one of the main tasks in modern diagnostics for the development of miniaturized in vitro test systems. This is critically important for both health and environmental diagnostics. The traditional approach (ELISA) is a time-consuming multistep process with sensitivity limitations due to usually used planar supports for detection. In this project we intend to develop a new approach for biosensing based on porous antibody microparticles. For this purpose, the combination of a new technique to assemble porous particles at mild conditions (host know-how) and highly sensitive ELISA-based detection system (applicant know-how) will be used. The porous particles will work as a platform with two crucial features: i) specific immunochemical reactions are realized on highly developed particle surface, ii) separation and detection in small volumes (micrometer dimensions). We believe that the proposed approach may open new avenues in future for effective diagnostics.
Funded Companies:
| Company name | Funding amount |
| FRAUNHOFER GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG e. V. | €159,461 |
Source: https://cordis.europa.eu/project/id/657079
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e. V., Munich, Germany.
The visualizations for "FRAUNHOFER GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG e. V. - EU funding (€159,461): Development of a new immunoassay platform based on porous antibody microparticles"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
